TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q3 2020. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $49,524 | -99.0% | 323,900 | -32.7% | 0.00% | -100.0% |
| Q3 2022 | $5,046,000 | +45.1% | 481,500 | +34.0% | 0.02% | +50.0% |
| Q2 2022 | $3,478,000 | +48.4% | 359,300 | +26.0% | 0.01% | +66.7% |
| Q1 2022 | $2,344,000 | +19.5% | 285,200 | +39.0% | 0.01% | +20.0% |
| Q4 2021 | $1,962,000 | +247.3% | 205,200 | +68.6% | 0.01% | +400.0% |
| Q3 2021 | $565,000 | -65.6% | 121,700 | -68.0% | 0.00% | -75.0% |
| Q2 2021 | $1,642,000 | -59.1% | 380,000 | -49.9% | 0.00% | -63.6% |
| Q1 2021 | $4,012,000 | +170.5% | 758,400 | +260.5% | 0.01% | +175.0% |
| Q4 2020 | $1,483,000 | +29.0% | 210,393 | +65.8% | 0.00% | +33.3% |
| Q3 2020 | $1,150,000 | -12.1% | 126,900 | +166.6% | 0.00% | -25.0% |
| Q2 2020 | $1,308,000 | +151.1% | 47,600 | +100.8% | 0.00% | +100.0% |
| Q1 2020 | $521,000 | – | 23,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |